U.S. drug regulators on Feb. 11 announced they are pushing back a decision on whether to authorize Pfizer’s COVID-19 vaccine for children as young as 6 months old.
In February 2020, the Trump administration drafted a policy document—stamped “not for public distribution or release” and indeed kept from public view for months—that would guide decision makers at every level of government and every sector of the economy in dealing with a new virus that came to be known by the scientific shorthand “Covid-19.”
Despite conclusive evidence young children have virtually no risk of severe complications or death from COVID-19, Pfizer, at the urging of federal health officials, is hustling to get infants and toddlers injected with experimental COVID vaccines.
The House on Friday passed the America COMPETES Act, a Democratic-driven bill that seeks to aid industries deemed necessary to compete with China in technology and manufacturing.
The National Institutes of Health has performed an experimental treatment for drug addicts by injecting cocaine into beagle puppies before killing them.